MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Identifying Incident Cases of Neurodegenerative Parkinsonism in a Large Observational At-Risk Cohort: the PPMI study

L. Chahine, K. Kieburtz, M. Brumm, C. Caspell-Garcia, C. Coffey, A. Siderowf, D. Weintraub, C. Tanner, T. Foroud, D. Galasko, B. Mollenhauer, T. Simuni, K. Marek (Pittsburgh, PA, USA)

Meeting: 2019 International Congress

Abstract Number: 822

Keywords: Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To examine the potential of a data-driven approach to identify incident cases of neurodegenerative parkinsonian disorders (PD) in a large observational cohort of individuals at risk for PD.

Background: Individuals at-risk for Parkinson’s disease and other neurodegenerative parkinsonian disorders who do not yet exhibit the motor syndrome and other features that fulfill clinical diagnostic criteria for one of these disorders serve as a prime population for disease-prevention therapies. The PPMI at-risk cohort was assembled to identify and characterize such individuals. Accurately identifying incident cases of neurodegenerative parkinsonism is critical to create predictive models and to design PD-prevention clinical trials.

Method: The at-risk PPMI cohort consists of individuals with one or more of the following features: idiopathic REM sleep behavior disorder (RBD, n=39), hyposmia (n=24) or non-manifesting carriers (NMC) of PD-pathogenic mutations (Leucine-rich repeat kinase 2 (LRRK2) gene (n=106) and glucocerebrosidase (GBA) gene (n=53) mutations)). Inclusion criteria enriched the RBD and hyposmia cohorts, but not the NMC cohort, with individuals with dopamine transporter binding deficit. A data-driven definition approach used rating scale and questionnaire responses indicating presence of bradykinesia and either rigidity or tremor to identify possible cases. The accuracy of this approach was compared to gold-standard of neurologist diagnosis based on at-least annual assessment. Data from a 2-year period of follow-up were used.

Results: The data-driven approach identified 32 possible cases (9 in the RBD group, 4 hyposmics, and 19 NMC carriers). Eight of these had received a clinical diagnosis of a neurodegenerative disorder: 7 with PD, 1 with MSA. Another 8 had been designated by the study site neurologist as having parkinsonism but had not yet received a specific diagnosis.

Conclusion: We demonstrate a sensitive method of using data collected during research study assessments to identify incident cases of PD in a large observational study of individuals at-risk for PD. Additional data from motor, non-motor, imaging, and biologic fluid biomarker assessments may be used to improve specificity.

To cite this abstract in AMA style:

L. Chahine, K. Kieburtz, M. Brumm, C. Caspell-Garcia, C. Coffey, A. Siderowf, D. Weintraub, C. Tanner, T. Foroud, D. Galasko, B. Mollenhauer, T. Simuni, K. Marek. Identifying Incident Cases of Neurodegenerative Parkinsonism in a Large Observational At-Risk Cohort: the PPMI study [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/identifying-incident-cases-of-neurodegenerative-parkinsonism-in-a-large-observational-at-risk-cohort-the-ppmi-study/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/identifying-incident-cases-of-neurodegenerative-parkinsonism-in-a-large-observational-at-risk-cohort-the-ppmi-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley